Page 33 - Influenza Report
P. 33
Golden Links 33
Golden Links
Influenza. Special Issue of the Journal of Emerging Infectious Diseases, 2006.
http://www.cdc.gov/ncidod/EID/index.htm
Pandemic Influenza: Confronting a Re-emergent Threat. Special Issue of the Journal of
Infectious Diseases, 1997.
http://www.journals.uchicago.edu/JID/journal/contents/v176nS1.html
Interviews
Interview with Dr. Jeffrey Taubenberger. Spanish and avian flu pandemics. Nature Podcast, 6
October 2006 http://www.nature.com/nature/podcast/v437/n7060/nature-2005-10-06.mp3
Interview with Dr. Frederick Hayden on antiviral resistance in influenza viruses. 23 February
2006 http://content.nejm.org/cgi/content/full/354/8/785/DC1
Interview with Dr. Anne Moscona on the clinical implications of oseltamivir resistance. 22
December 2005 http://content.nejm.org/cgi/content/full/353/25/2633/DC1
Interview with Dr. Michael Osterholm on preparing for an influenza pandemic. 5 May 2005
http://content.nejm.org/cgi/content/full/352/18/1839/DC1
References
1. Amonsin A, Payungporn S, Theamboonlers A, et al. Genetic characterization of H5N1
influenza A viruses isolated from zoo tigers in Thailand. Virology 2006; 344: 480-91. Epub 2005
Sep 27. Abstract: http://amedeo.com/lit.php?id=16194557
2. Aoki FY, Macleod MD, Paggiaro P, et al. Early administration of oral oseltamivir increases
the benefits of influenza treatment. J Antimicrob Chemother 2003; 51: 123-9. Abstract:
http://amedeo.com/lit.php?id=12493796 Full text at
http://jac.oxfordjournals.org/cgi/content/full/51/1/123
3. Apisarnthanarak A, Kitphati R, Thongphubeth K, et al. Atypical avian influenza (H5N1).
Emerg Infect Dis 2004; 10: 1321-4. http://www.cdc.gov/ncidod/EID/vol10no7/04-0415.htm
4. Balicer RD, Huerta M, Davidovitch N, Grotto I. Cost-benefit of stockpiling drugs for
influenza pandemic. Emerg Infect Dis 2005; 11: 1280-2. Abstract:
http://amedeo.com/lit.php?id=16102319 Full text at
http://www.cdc.gov/ncidod/EID/vol11no08/04-1156.htm
5. Barry JM. 1918 revisited: lessons and suggestions for further inquiry. In: Board on Global
Health. The Threat of Pandemic Influenza: Are We Ready? The National Academies Press
2004. Available from http://darwin.nap.edu/books/0309095042/html/58.html
6. Basler CF, Reid AH, Dybing JK, et al. Sequence of the 1918 pandemic influenza virus
nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918
NS genes. Proc Natl Acad Sci U S A 2001; 98: 2746-51. Abstract:
http://amedeo.com/lit.php?id=11226311 Full text at
http://www.pnas.org/cgi/content/full/98/5/2746
7. Behrens G, Stoll M. Pathogenesis and Immunology. In: Influenza Report. Kamps BS,
Hoffmann C, Preiser W. Flying Publisher, Wuppertal, 2006. Full text at
http://www.influenzareport.com/ir/pathogen.htm
8. Bright RA, Medina MJ, Xu X, et al. Incidence of adamantane resistance among influenza
A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005;
366: 1175-81. Epub 2005 Sep 22. Abstract: http://amedeo.com/lit.php?id=16198766